INC Research Further Demonstrates Commitment to Drug Development Communities through Unveiling of New Brand Campaign
(Thomson Reuters ONE) -
Company's "Can do, I own it" culture and insights from extensive market research
drive renewed commitment to forging deeper connections across the clinical
development process
Raleigh, N.C., Nov. 12, 2013 - INC Research, a therapeutically focused global
clinical research organization (CRO) with a Trusted Process(® )for delivering
reliable results, has unveiled a new brand campaign, "I am INC Research," that
illustrates how the Company keeps customers, investigative sites and patients
more connected throughout the entire clinical development process.
"Over the past two years, our Company has grown not only in size, but in scale
and in therapeutic reach," said INC Research CEO Jamie Macdonald. "To further
engage our employees in continuously improving the quality of our delivery to
customers and create a 'Can do, I own it' culture, we took a hard look at
ourselves and the perception of CROs as a whole. Every one of us that works at
or with INC plays an integral role in developing the medicines that people need.
As an industry, we all share this goal, but as a Company we discovered many of
the practices we've implemented demonstrate a different way of doing business,
one that resonates with our customers and the way they wish to be treated."
Working with market research company Industry Standard Research, INC Research
conducted extensive primary research, including in-depth interviews with senior
leaders from more than 120 mid-sized and large pharma customers in Europe and
the United States. The research showed that CROs, in general, are viewed as not
being as connected to the success of their sponsors' compounds as sponsors would
like them to be. They also expressed a desire for CROs to show a greater sense
of proactive involvement or "skin in the game."
"In an effort to better connect with our customers, we started to explore where
we were different and found a common theme," explained Neil Ferguson, Executive
Vice President, Global Business Development at INC Research. "We discovered that
INC is able to fill a gap that exists in the market to drive deeper connections
with drug development communities, a position we can uniquely own. Recognizing
how powerful this is to our customers led us to develop our new brand campaign."
Among the key elements of the campaign is a brief video demonstrating how INC
Research seamlessly connects with sites and investigators, customers, patients
and data to ultimately bring new drugs to market for its customers and the
patients served by the entire drug development community. The initial rollout
also consists of a series of six advertisements, highlighting key roles and
their connection with INC Research in delivering new therapies to patients.
"The end game is all about delivering new therapies to patients," continued
Ferguson. "The common thread is that each and every person our customers
interact with at INC Research is as connected and committed to their clinical
trials and their compounds as they are. This sentiment is encapsulated in our
new tagline: 'Developing the medicines people need is something we take
personally.'"
To view how INC Research connects with customers, investigative sites and
patients to bring new medicines to market on time and on budget, watch our
powerful new film here. For more information on INC Research's new global brand
campaign, visit www.incresearch.com.
About INC Research
INC Research is a therapeutically focused clinical research organization with a
high-performance reputation for conducting global clinical development
programs of the highest integrity. Pharmaceutical and biotechnology companies
look to us for a complete range of customized Phase I to IV programs in
all therapeutic areas and patient populations. Our Trusted Process® methodology
and therapeutic foresight lead customers to better-informed product development
decisions, while our solid site relationships are a critical success factor in
delivering clinical trial results on time and on budget. INC was ranked "Top
CRO" by sites worldwide in the 2013 CenterWatch Global Investigative Site
Relationship Survey. INC Research is headquartered in Raleigh, NC. For more
information, please visit www.incresearch.com or follow us at (at)inc_research.
Contact: Lori Dorer, Media +1 (513) 345-1685
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
[HUG#1742254]
Unternehmensinformation / Kurzprofil:
Datum: 12.11.2013 - 14:11 Uhr
Sprache: Deutsch
News-ID 315468
Anzahl Zeichen: 5328
contact information:
Town:
Raleigh
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 164 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"INC Research Further Demonstrates Commitment to Drug Development Communities through Unveiling of New Brand Campaign"
steht unter der journalistisch-redaktionellen Verantwortung von
INC RESEARCH, LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
